Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ShuGanHeWei (shugan hewei) is a traditional Chinese medicine (TCM) herbal formulation designed to "soothe the liver and harmonize the stomach." It is widely used in China for gastrointestinal disorders such as chronic atrophic gastritis and gastroesophageal reflux disease (GERD), especially when associated with symptoms like poor appetite, abdominal pain or fullness, nausea, vomiting, acid regurgitation, and abnormal bowel movements. The formula contains multiple herbal ingredients including Bupleurum falcatum root (chai hu), Atractylodes macrocephala root (bai zhu), Paeonia lactiflora root (bai shao), Citrus medica fruit (fo shou), Citrus reticulata peel (chen pi), Curcuma longa stem (yu jin), Saussurea costus root (mu xiang), Cyperus rotundus rhizome (xiang fu), Glycyrrhiza uralensis root/rhizome (gan cao), Lindera strychnifolia root (wu yao), Pogostemon cablin herb (huo xiang), Raphanus sativus fruit/lai fu zi and others[4][5]. Mechanistically, network pharmacology studies suggest that its main active compounds include quercetin, kaempferol and luteolin. These act on targets involved in inflammation and immunity such as TGF-β1, IL-1β/IL-4/IL-10/IL-2/CXCL8/CXCL10/MAPK1/MAPK3/FOS. For mental health comorbidities like anxiety/depression with GERD it may modulate GABA-A receptor subunits GABRA1/GABRA2/GABRA3/GABRA5/GABRA6[3]. Clinical studies show efficacy for refractory GERD—especially when combined with rabeprazole—and chronic atrophic gastritis; it improves both GI symptoms and quality of life measures[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on shugan hewei.